These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 3168017)

  • 1. [Serologic incompatibility and family planning].
    Matýsek P; Ungerová A; Cuprová M; Muchová M
    Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
    Huang HJ; Tagawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual case of isoimmunization by D, Cellano (k) and Duffy (Fyb) antigens.
    Chojnacka-Jachimiak I; Seyfried H; Koziołowa H
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):585-91. PubMed ID: 4952639
    [No Abstract]   [Full Text] [Related]  

  • 5. [A clinical case of pregnancy isoimmunization caused by the Kell system].
    Orsini G; Serratì A; Schonauer S; Cramarossa D
    Minerva Ginecol; 1977 Oct; 29(10):727-30. PubMed ID: 593610
    [No Abstract]   [Full Text] [Related]  

  • 6. Red cell antigens. The fetus as a patient.
    Huntley B
    Lancet; 2001 Dec; 358 Suppl():S58. PubMed ID: 11784607
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-Rh0 (D) hemolytic disease of the newborn: an obstetric viewpoint.
    Zlatnik FJ
    Semin Perinatol; 1977 Apr; 1(2):169-75. PubMed ID: 754292
    [No Abstract]   [Full Text] [Related]  

  • 8. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid.
    Berkowitz RL; Beyth Y; Sadovsky E
    Obstet Gynecol; 1982 Dec; 60(6):746-9. PubMed ID: 7145281
    [No Abstract]   [Full Text] [Related]  

  • 9. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemolytic disease of the newborn caused by maternal allo-immunization against erythrocyte antigens other than A, B and rhesus D].
    Monestier M; Rigal D; Juron-Dupraz F; Meyer F
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):671-80. PubMed ID: 6520354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 12. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management.
    Wenk RE; Goldstein P; Felix JK
    Obstet Gynecol; 1985 Oct; 66(4):473-6. PubMed ID: 3931011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome in mothers who develop Kell antibodies.
    Farr V; Gray E
    Scott Med J; 1988 Aug; 33(4):300-3. PubMed ID: 3055288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perinatal research on feto-maternal anti-Kell immunization].
    Gavriil P; Jauniaux E; Lambermont M; Donner C; Avni FE; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):761-4. PubMed ID: 2689503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
    Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
    Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of leukocytic isosensitization in pregnancy on the condition of the newborn infant].
    Kuznechikova VV; Vasil'eva ZF; Poliakova GP
    Vopr Okhr Materin Det; 1971 Jan; 16(1):40-5. PubMed ID: 4995798
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early determination of ABO incompatibility. Catamnestic studies of 141 pregnancies with suspicion or clinical evidence of ABO incompatibility].
    Kröger E; Scherbening G
    Munch Med Wochenschr; 1969 Nov; 111(46):2388-92. PubMed ID: 5394823
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allo-immunization against antigens from non-D blood groups. Value of detection].
    Mannessier L; Goudemand M; Delecour M
    Lille Med; 1980 Mar; 25(3):90-3. PubMed ID: 6768941
    [No Abstract]   [Full Text] [Related]  

  • 19. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn caused by rarely occurring antibodies to various blood group systems].
    Maszkiewicz W; Ornat K; Zarczyńska B; Bagińska T; Irzyńska D
    Acta Haematol Pol; 1988; 19(1-2):77-80. PubMed ID: 3149115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.